MindMaze Therapeutics SA 

€0.3201
79
+€0.00+0% Tuesday 07:10

Statistics

Day High
0.3201
Day Low
0.3201
52W High
2.74
52W Low
0.3201
Volume
-
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow V6M0.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences is a biopharmaceutical company that competes in developing treatments for viral diseases, a similar area of focus as Relief Therapeutics.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals is involved in developing medications for serious medical conditions, directly competing with Relief Therapeutics in the biopharmaceutical space.
Moderna
MRNA
Mkt Cap31.65B
Moderna is known for its mRNA technology used in vaccines and therapies, competing with Relief Therapeutics in the innovative treatment sector.
Pfizer
PFE
Mkt Cap138.61B
Pfizer develops and manufactures drugs and vaccines, including treatments for COVID-19, making it a competitor in the pandemic response market.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca is a global biopharmaceutical company working on vaccines and treatments for various diseases, including COVID-19, competing with Relief Therapeutics.
BioNTech
BNTX
Mkt Cap24.67B
BioNTech SE, in partnership with Pfizer, developed a COVID-19 vaccine, directly competing with Relief Therapeutics' efforts in pandemic-related treatments.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson, through its pharmaceutical division, develops treatments and vaccines, including for COVID-19, competing in the same space as Relief Therapeutics.
Novavax
NVAX
Mkt Cap1.6B
Novavax is focused on developing vaccines, including for COVID-19, making it a direct competitor in the vaccine development space.
Sorrento Therapeutics
SRNE
Mkt Cap303,204
Sorrento Therapeutics works on therapies for COVID-19, cancer, and pain, competing with Relief Therapeutics in multiple therapeutic areas.

About

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Show more...
CEO
Mr. Zachery W. Henderson
Employees
10
Country
Switzerland
ISIN
US60269B1052

Listings

0 Comments

Share your thoughts

FAQ

What is MindMaze Therapeutics SA stock price today?
The current price of V6M0.MU is €0.32 EUR — it has increased by +0% in the past 24 hours. Watch MindMaze Therapeutics SA stock price performance more closely on the chart.
What is MindMaze Therapeutics SA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange MindMaze Therapeutics SA stocks are traded under the ticker V6M0.MU.
How many employees does MindMaze Therapeutics SA have?
As of July 10, 2026, the company has 10 employees.
In which sector is MindMaze Therapeutics SA located?
MindMaze Therapeutics SA operates in the Other sector.
When did MindMaze Therapeutics SA complete a stock split?
The last stock split for MindMaze Therapeutics SA was on May 05, 2023 with a ratio of 1:2.
Where is MindMaze Therapeutics SA headquartered?
MindMaze Therapeutics SA is headquartered in Geneva, Switzerland.